ID Business Solutions (IDBS) has begun its twentieth year, having shown robust growth, profitability and advances in product development in 2008.
Neil Kipling, founder and chief executive officer of IDBS, said: 'Interim results from 2008 show continued increase in revenue and profitability resulting from a rapid sales growth of the company's electronic workbook suite (E-Workbook) and increased adoption of Activitybase XE - the latest development for in-vitro data management.' 'Particularly encouraging has been the uptake of our solutions in regulated research environments, such as drug metabolism, toxicology and process development,' added Kipling.
'In addition, the market gave a very positive reception to our chemistry tool set, which is competing strongly and replacing existing legacy solutions that have not kept pace with the changing environment within RandD.' 'With our clients already reporting 20 to 30 per cent efficiency savings directly accountable to the implementation of our solutions, we will continue to work hard to maximise their benefit.'
